3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
28
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumours
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Radiotherapy
11
Cisplatin
10
Paclitaxel
9
pembrolizumab
7
Fluorouracil
7
Oxaliplatin
6
Irinotecan
6
tislelizumab
5
Cetuximab
5
Docetaxel
4
Radiation
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
Capecitabine
3
Neoadjuvant Therapy
2
Immunohistochemistry
2
Biopsy
2
10-propargyl-10-deazaaminopterin
2
tremelimumab
1
sitravatinib
1
sintilimab
1
regorafenib
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
durvalumab
1
cixutumumab
1
adavosertib
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Squamous Cell Carcinoma
×
abiraterone
×
Clear all
No trials found.